Alyson Barton, NP
Family · Arlington, TXNPI 1154090264
Payments from drug & device makers
Across 150 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$295
- Novo Nordisk$268
- AbbVie$228
- Pfizer$212
- Novartis$161
- AstraZeneca$135
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,54999%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $295 |
| Novo Nordisk | 14 | $268 |
| AbbVie | 21 | $228 |
| Pfizer | 12 | $212 |
| Novartis | 10 | $161 |
| AstraZeneca | 8 | $135 |
| Merck | 8 | $119 |
| Bausch Health US, LLC | 6 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $99 |
| Bayer | 5 | $93 |
| Sanofi-aventis U.S. LLC | 4 | $88 |
| Boston Scientific | 2 | $73 |
| Currax Pharmaceuticals LLC | 4 | $73 |
| Astellas Pharma US Inc | 4 | $70 |
| GSK | 3 | $64 |
| Exact Sciences | 4 | $62 |
| Amarin Pharma, Inc. | 3 | $60 |
| Amgen | 4 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Gilead | 1 | $21 |
| Medtronic | 1 | $21 |
| Biotronik Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Johnson & Johnson | 1 | $12 |
How this compares
$2,574 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 72 | $788 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $578 |
| Fluticasone Propionate | 33 | $487 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $472 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $411 |
| Ciprofloxacin Hcl | 42 | $402 |
| Amlodipine Besylate | 17 | $297 |
| Diclofenac Sodium | 11 | $235 |
| Rosuvastatin Calcium | 13 | $189 |
| Montelukast Sodium | 25 | $183 |
| Lisinopril | 16 | $162 |
| Azithromycin | 50 | $159 |
| Omeprazole | 11 | $140 |
| Tizanidine Hcl | 11 | $138 |
| Prednisone | 37 | $137 |
Paid to pharmacies, not to this prescriber.
Other family in Arlington
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.